Filing Details
- Accession Number:
- 0001140361-16-059675
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-31 14:37:20
- Reporting Period:
- 2016-03-30
- Filing Date:
- 2016-03-31
- Accepted Time:
- 2016-03-31 14:37:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 776008 | Rock Creek Pharmaceuticals Inc. | RCPI | Medicinal Chemicals & Botanical Products (2833) | 521402131 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1604257 | Robert Scannell | C/O Rock Creek Pharmaceuticals, Inc. 2040 Whitfield Ave., Suite 300 Sarasota FL 34243 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-03-30 | 285,714 | $0.35 | 285,714 | No | 4 | P | Indirect | By IASO Advisors LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By IASO Advisors LLC |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant (right to buy) | Acquisiton | 2016-03-30 | 571,428 | $0.00 | 571,428 | $1.12 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 571,428 | 2016-03-30 | 2023-03-30 | No | 4 | P | Indirect |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 307,915 | Indirect | By Feehan Partners, LP |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to Purchase Common Stock | $0.87 | 2025-11-17 | 2,000 | 2,000 | Direct | |
| Common Stock | Warrant (right to buy) | $3.00 | 2019-05-08 | 2022-05-08 | 69,831 | 69,831 | Indirect |
| Common Stock | Warrant (right to buy) | $3.75 | 2015-01-28 | 2022-01-27 | 6,003 | 6,003 | Indirect |
| Common Stock | Warrant (right to buy) | $25.00 | 2014-08-08 | 2021-08-08 | 50,000 | 50,000 | Indirect |
| Common Stock | Warrant (right to buy) | $25.00 | 2014-08-08 | 2021-08-08 | 7,000 | 7,000 | Indirect |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2025-11-17 | 2,000 | 2,000 | Direct |
| 2022-05-08 | 69,831 | 69,831 | Indirect |
| 2022-01-27 | 6,003 | 6,003 | Indirect |
| 2021-08-08 | 50,000 | 50,000 | Indirect |
| 2021-08-08 | 7,000 | 7,000 | Indirect |
Footnotes
- The reporting person is the principal owner of IASO Advisors LLC.
- Feehan Partners, LP is a family limited partnership controlled by the reporting person.
- Options to purchase common stock, granted pursuant to the issuer's Third Amended and Restated 2008 Incentive Award Plan, are exercisable as follows: 50% on the first anniversary of the date of grant and 100% on the second anniversary of the date of grant.
Billionaire Hedge Funds
